TCRT icon

Alaunos Therapeutics

122 hedge funds and large institutions have $356M invested in Alaunos Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0.01% less ownership

Funds ownership: 0.28%0.27% (-0.01%)

5% less capital invested

Capital invested by funds: $376M → $356M (-$19.8M)

47% less call options, than puts

Call options by funds: $4.96M | Put options by funds: $9.29M

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.96M
Puts
$9.29M
Net Calls
Net Calls Change

Top Buyers

1 +$2.81M
2 +$1.98M
3 +$872K
4
Goldman Sachs
Goldman Sachs
New York
+$823K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$764K
Name Holding Trade Value Shares
Change
Change in
Stake
76
$158K
77
$147K
78
$145K
79
$144K
80
$141K
81
$125K
82
$110K
83
$109K
84
$105K
85
$104K
86
$102K
87
$100K
88
$96K
89
$91K
90
$86K
91
$83.6K
92
$80K
93
$76K
94
$74K
95
$73K
96
$68K
97
$67K
98
$65K
99
$63K
100
$63K